Provided by Tiger Trade Technology Pte. Ltd.

Arvinas Holding Company LLC

9.37
+0.34003.77%
Post-market: 9.370.00000.00%19:30 EDT
Volume:951.75K
Turnover:8.84M
Market Cap:612.34M
PE:70.06
High:9.39
Open:9.02
Low:9.00
Close:9.03
52wk High:14.51
52wk Low:6.97
Shares:65.39M
Float Shares:56.67M
Volume Ratio:1.77
T/O Rate:1.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1337
EPS(LYR):-1.1400
ROE:1.59%
ROA:-1.01%
PB:1.09
PE(LYR):-8.21

Loading ...

BofA Securities Raises Price Target on Arvinas to $16 From $14

MT Newswires Live
·
May 14

U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology

Reuters
·
May 14

Arvinas Inc : Leerink Partners Cuts Target Price to $9 From $18

THOMSON REUTERS
·
May 14

Arvinas price target raised to $16 from $14 at BofA

TIPRANKS
·
May 14

These Analysts Increase Their Forecasts On Arvinas After Q1 Results

Benzinga Earnings
·
May 14

Arvinas Is Maintained at Buy by BTIG

Dow Jones
·
May 13

Arvinas Holding Company (ARVN) Receives a Buy from Wells Fargo

TIPRANKS
·
May 13

Arvinas price target raised to $20 from $18 at Barclays

TIPRANKS
·
May 13

U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic

Reuters
·
May 13

Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN) and Sensus Healthcare (SRTS)

TIPRANKS
·
May 13

H.C. Wainwright says Pfizer handing off Veppanu to Rigel ‘makes strategic sense’

TIPRANKS
·
May 13

BUZZ-U.S. STOCKS ON THE MOVE-Tyler Technologies, Autodesk, Illumina

Reuters
·
May 13

Arvinas Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

BUZZ-U.S. STOCKS ON THE MOVE-Under Armour, C3 AI, Rigel Pharma

Reuters
·
May 12

Arvinas Grants Rigel Global Rights to VEPPANU Therapy

TIPRANKS
·
May 12

Arvinas publishes corporate presentation on PROTAC protein degraders in cancer, neurodegenerative diseases

Reuters
·
May 12

Arvinas, Pfizer Tap Rigel Pharmaceuticals to Bring Veppanu to Market

Dow Jones
·
May 12

Arvinas Q1 sales miss estimates on lower collaboration revenue from Pfizer

Reuters
·
May 12

Arvinas Q1 EPS $(0.90) Misses $(0.87) Estimate, Sales $15.600M Miss $18.097M Estimate

Benzinga Earnings
·
May 12

BRIEF-Arvinas Q1 Operating Expenses USD 79.4 Million

Reuters
·
May 12